STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
18.53
-0.31 (-1.65%)
Mar 16, 2026, 12:19 PM EDT - Market open
STAAR Surgical Company Employees
STAAR Surgical Company had 921 employees as of January 2, 2026. The number of employees decreased by 236 or -20.40% compared to the previous year.
Employees
921
Change (1Y)
-236
Growth (1Y)
-20.40%
Revenue / Employee
$259,980
Profits / Employee
-$87,349
Market Cap
917.47M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jan 2, 2026 | 921 | -236 | -20.40% | 921 | 0 |
| Dec 27, 2024 | 1,157 | 100 | 9.46% | 1,157 | 0 |
| Dec 29, 2023 | 1,057 | 165 | 18.50% | 1,056 | 1 |
| Dec 30, 2022 | 892 | 191 | 27.25% | 882 | 10 |
| Dec 31, 2021 | 701 | 126 | 21.91% | 692 | 9 |
| Jan 1, 2021 | 575 | 25 | 4.55% | 575 | 0 |
| Jan 3, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jan 1, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| DENTSPLY SIRONA | 14,000 |
| Warby Parker | 4,036 |
| Azenta | 3,000 |
| Embecta | 1,850 |
| AtriCure | 1,350 |
| AngioDynamics | 675 |
| LeMaitre Vascular | 655 |
| Kestra Medical Technologies | 330 |
STAA News
- 12 days ago - STAAR Surgical Company (STAA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - STAAR Surgical Issues Shareholder Letter - Business Wire
- 12 days ago - STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results - Business Wire
- 18 days ago - STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction - Business Wire
- 20 days ago - STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026 - Business Wire
- 26 days ago - FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction - Business Wire
- 6 weeks ago - STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs - Business Wire
- 2 months ago - STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence - Benzinga